Key Findings:  The authors summarize that anti-inflammatory agents, vitamin D3-receptor analogs, and cannabinoids represent treatment modalities currently under investigation for use in LUTS patients.
Type of Study:  Meta-analysis
Study Result:  Positive
Research Location(s):  Greece
Year of Pub:  2016
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Unspecified
Citation:  Dimitropoulos K and Gravas S. New therapeutic strategies for the treatment of male lower urinary tract symptoms. Res Rep Urol. 2016; 8:51-9. doi: 10.2147/RRU.S63446
Authors:  Dimitropoulos K, Gravas S